Elutia Chairman's $74K Stock Purchase Signals Insider Confidence Amidst Sector Turbulence
Elutia Inc.'s independent chairman Kevin Rakin invested $74,000 in company shares last week, marking the largest insider buy in the past year. The move comes as the medical technology firm navigates a challenging market for early-stage healthcare innovators.